EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD19 and FcγRIIb co-engagement inhibits processes essential to T cell–dependent B-cell responses

Daniel M Morelli iD, Heather C Craig, Xiao Feng, Michele Youd, Mark I Matijevic, Steven M Kerfoot iD

The Journal of Immunology · 21.01.2026 · 215 (1)

DOI: 10.1093/jimmun/vkaf247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 22.09.2025. Verfasst von Daniel M Morelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada. Hauptthemen laut MEDLINE: Antigens, CD19, Receptors, IgG, B-Lymphocytes, T-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zenas BioPharma, MS Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obexelimab is an investigational, bifunctional humanized monoclonal antibody that inhibits B-lineage cells by binding CD19 via its Fab region and simultaneously co-engaging the inhibitory receptor FcγRIIb through a modified Fc region. Interactions between B cells and T cells specific for the same Ag are essential for the development of germinal center (GC) B-cell responses and high-affinity antibodies. Mutant mice expressing human FcγRIIb and a mouse obexelimab surrogate (mObx) were used to determine if mObx inhibits these critical interactions between cognate B cells and T cells. In ex vivo experiments, mObx blocked B-cell receptor (BCR)–mediated uptake of Ag-coated beads by splenic follicular (Fo) and marginal zone (MZ) B cells and peritoneal cavity (PerC) B1 cells. Similarly, obexelimab treatment of human B cells significantly reduced BCR-mediated bead uptake ex vivo. mObx-treatment inhibited Ag presentation by splenic B cells to co-cultured T cells, as T-cell proliferation and expression of activation markers CD25 and CD44 were significantly reduced when mObx, but not control anti-CD19 antibody, was added to the co-culture. Finally, prophylactic treatment of mice with mObx effectively blocked the activation of human FcγRIIb-expressing B cells and the development of an Ag-specific GC response in vivo. Treatment after GC onset resulted in dissolution of the GC. Collectively, these data demonstrate that CD19/FcγRIIb co-engagement effectively suppresses processes essential to support T cell–dependent B-cell responses, which is consistent with the proposed mechanism of action of obexelimab.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, CD19Receptors, IgGB-LymphocytesT-LymphocytesAnimalsMiceHumansAntibodies, Monoclonal, HumanizedLymphocyte ActivationCoculture TechniquesAntigen PresentationMice, Inbred C57BLGerminal CenterCell Communication

Stichwörter der Autor:innen

B cellT cellantigen presentationhumanmouse

Substanzen

Antigens, CD19Receptors, IgGAntibodies, Monoclonal, HumanizedFc gamma receptor IIB

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
  • Zenas BioPharma, Waltham, MA, United States.

ORCID-Profile: Daniel M Morelli, Steven M Kerfoot

Förderung

  • Zenas BioPharma
  • MS Canada

Zitieren

APA

Morelli, D. M., Craig, H. C., Feng, X., Youd, M., Matijevic, M. I., & Kerfoot, S. M. (2026). CD19 and FcγRIIb co-engagement inhibits processes essential to T cell–dependent B-cell responses. The Journal of Immunology, 215(1). https://doi.org/10.1093/jimmun/vkaf247

Vancouver

Morelli DM, Craig HC, Feng X, Youd M, Matijevic MI, Kerfoot SM. CD19 and FcγRIIb co-engagement inhibits processes essential to T cell–dependent B-cell responses. The Journal of Immunology. 2026;215(1). doi:10.1093/jimmun/vkaf247

BibTeX
@article{Morelli2026,
  author = {Morelli, Daniel M and Craig, Heather C and Feng, Xiao and Youd, Michele and Matijevic, Mark I and Kerfoot, Steven M},
  title = {CD19 and FcγRIIb co-engagement inhibits processes essential to T cell–dependent B-cell responses},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {1},
  doi = {10.1093/jimmun/vkaf247}
}
Kostenlos starten →